Hamm J, Dathan N A, Mattaj I W
European Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany.
Cell. 1989 Oct 6;59(1):159-69. doi: 10.1016/0092-8674(89)90878-7.
Methods for studying pre-mRNA splicing in Xenopus oocytes have been improved to allow simultaneous analysis of the splicing reaction and the formation of splicing complexes in vivo. The number, order of appearance, and dependence on intact U1 and U2 snRNPs of complexes formed in vivo on a pre-mRNA substrate are similar but not identical to those observed in vitro. The migration on native gels of the complexes formed in vivo and in vitro is, however, dissimilar. RNAase H-mediated inhibition of splicing caused by oligonucleotide microinjection can be overcome by coinjection of a gene encoding the U snRNA that is targeted for cleavage. Transcripts from the injected gene complement the defect in splicing by assembling into functionally active U snRNPs. Using this assay, mutant U2 snRNAs have been tested for their ability to function in splicing and in splicing complex formation. The results indicate that much of the U2 snRNA, including regions essential for detectable binding of the U2-specific proteins A' and B", is dispensable for splicing.
研究非洲爪蟾卵母细胞中前体mRNA剪接的方法已经得到改进,能够在体内同时分析剪接反应和剪接复合体的形成。在体内,在一个前体mRNA底物上形成的复合体的数量、出现顺序以及对完整的U1和U2 snRNP的依赖性,与在体外观察到的情况相似但并不完全相同。然而,体内和体外形成的复合体在天然凝胶上的迁移情况是不同的。通过寡核苷酸显微注射导致的RNA酶H介导的剪接抑制,可以通过共注射编码被靶向切割的U snRNA的基因来克服。注射基因的转录本通过组装成功能活跃的U snRNP来弥补剪接缺陷。利用这种检测方法,已经对突变的U2 snRNA在剪接和剪接复合体形成中的功能进行了测试。结果表明,U2 snRNA的大部分,包括对U2特异性蛋白A'和B"可检测结合至关重要的区域,对于剪接来说是可有可无的。